SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-22-208779
Filing Date
2022-08-01
Accepted
2022-08-01 16:42:42
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 d325463ds3.htm S-3 334178
2 EX-4.4 d325463dex44.htm EX-4.4 306658
3 EX-4.6 d325463dex46.htm EX-4.6 100420
4 EX-4.7 d325463dex47.htm EX-4.7 99792
5 EX-4.8 d325463dex48.htm EX-4.8 86634
6 EX-5.1 d325463dex51.htm EX-5.1 23961
7 EX-23.1 d325463dex231.htm EX-23.1 2091
8 EX-FILING FEES d325463dexfilingfees.htm EX-FILING FEES 55618
9 GRAPHIC g325463g01a03.jpg GRAPHIC 63827
10 GRAPHIC g325463g97t69.jpg GRAPHIC 2733
  Complete submission text file 0001193125-22-208779.txt   1096913
Mailing Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131
Business Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131 (408) 457-3700
Rani Therapeutics Holdings, Inc. (Filer) CIK: 0001856725 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-266444 | Film No.: 221125396
SIC: 2834 Pharmaceutical Preparations